乙细胞淋巴瘤6 (BCL6):免疫力和超越的保护调节剂
Clifford Liongue1,2, Farooq L J Almohaisen1,3, Alister C Ward1,2
1School of Medicine, Deakin University, Geelong, VIC 3216, Australia.
International journal of molecular sciences
|October 26, 2024
概括
B细胞淋巴瘤6 (BCL6) 是一个重要的转录抑制剂,调节免疫细胞的发育和功能. 它在生殖中心和癌症,特别是淋巴瘤中的作用突显了对BCL6抑制剂的需求.
科学领域:
- 分子生物学分子生物学
- 免疫学 免疫学 免疫学
- 在瘤学瘤学.
背景情况:
- B细胞淋巴瘤6 (BCL6) 是一种保存的转录抑制蛋白.
- BCL6在免疫细胞发育中起着关键作用,包括生殖中心的形成和抗体的产生.
- 它的功能超越免疫力,调节巨细胞活动和其他细胞过程.
研究的目的:
- 总结BCL6在生物系统中的多方面的作用.
- 强调BCL6在免疫细胞调节和癌症生物学中的重要性.
- 为了强调针对BCL6.6的治疗潜力.
主要方法:
- 文献综述和对BCL6.6现有研究的综合.
- 对BCL6在不同物种中保存的功能进行分析.
- 检查BCL6在人类癌症和治疗耐药性的参与.
主要成果:
- BCL6对于生殖中心的形成,高亲和抗体的发展以及Tfh和Tfr细胞的功能至关重要.
- BCL6调节巨细胞的产生和功能,在整个进化过程中保留了作用.
- BCL6基因与扩散性大B细胞淋巴瘤 (DLBCL) 和卵泡淋巴瘤 (FL) 有关,并有助于治疗耐药性.
结论:
- BCL6是一种关键的调节器,在免疫和其他系统中具有保留的功能.
- 对BCL6的失调是淋巴发育和治疗挑战的核心.
- BCL6 抑制剂代表了对各种癌症的有希望的治疗策略.
相关概念视频
B Cell Activation and Differentiation
1.6K
The adaptive immune response, a sophisticated defense mechanism, relies on the activation and differentiation of B lymphocytes, or B cells. These processes enable our bodies to mount a tailored response against specific pathogens such as bacteria, free virus particles, toxins, and parasites.
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...
1.6K
Special Features of Adaptive Immunity
764
The adaptive immune system, a crucial component of the overall immune response, offers a highly specialized defense against pathogens. It involves specific cell types and features, enabling it to combat infections effectively and efficiently.
The primary cell types involved in adaptive immunity are T cells and B cells. Each type has a unique role in defending the body against pathogens. T cells are responsible for cell-mediated immunity. They identify and eliminate infected cells directly,...
The primary cell types involved in adaptive immunity are T cells and B cells. Each type has a unique role in defending the body against pathogens. T cells are responsible for cell-mediated immunity. They identify and eliminate infected cells directly,...
764
Cells of the Adaptive Immune Response
967
The T and B lymphocytes of the adaptive immune system develop from common lymphoid progenitor cells in the bone marrow. These progenitors give rise to precursors that eventually develop into both T and B lymphocytes. As these precursors mature, they gain the ability to detect and respond to foreign antigens in the body, a process known as immunocompetence. Additionally, these precursors acquire self-tolerance, a process that ensures they do not react to self-antigens. This intricate system...
967
Diversity of Antigen Receptors
531
Antigen receptors are essential components of the immune system crucial in defending the body against foreign invaders. These receptors are present on the surface of B and T cells, enabling them to recognize antigens and mount an appropriate immune response.
Before encountering any antigen, lymphocytes express these receptors. On B cells, the antigen receptor is a membrane-bound antibody molecule called BCR; on T cells, it is a T cell receptor or TCR. B and T cell receptors are composed of two...
Before encountering any antigen, lymphocytes express these receptors. On B cells, the antigen receptor is a membrane-bound antibody molecule called BCR; on T cells, it is a T cell receptor or TCR. B and T cell receptors are composed of two...
531
Regulation of Hematopoietic Stem Cells
3.1K
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
3.1K
NF-κB-dependent Signaling Pathway
7.2K
The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
NF-κB-dependent Signaling Mechanism
The...
7.2K


